Sanjana Lab - New York Genome Center

Sanjana Lab of NYGC/NYU Extends RNA-Targeting CRISPR-Cas13 Genomics Tools to Model Organisms and Viruses Including SARS-CoV-2

NEW YORK, NY (August 30, 2021) – Last year, researchers in the lab of Neville Sanjana, PhD, at the New York Genome Center (NYGC) and New York University (NYU) unveiled a suite of CRISPR-based tools to probe RNA in human cells in a high-throughput fashion using a RNA-targeting CRISPR enzyme (Cas13). Now, as detailed in a […]

Faculty Labs

NYGC Labs

Blog Archives

Efficient combinatorial targeting of RNA transcripts in single cells with Cas13 RNA Perturb-seq.

Automated design of CRISPR prime editors for thousands of human pathogenic variants.

Transcriptome-wide Cas13 guide RNA design for model organisms and viral RNA pathogens.

Sanjana Lab of NYGC/NYU Extends RNA-Targeting CRISPR-Cas13 Genomics Tools to Model Organisms and Viruses Including SARS-CoV-2

Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus.

Voices of the new generation: open science is good for science (and for you).